Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination
Clinical Chemistry · 03.04.2024 · 70 (4) · 589-596
DOI: 10.1093/clinchem/hvad169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Chemistry, online erschienen am 01.12.2023. Verfasst von Christopher D Heaney und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background SARS-CoV-2 variants continue to circulate globally, even within highly vaccinated populations. The first-generation SARS-CoV-2 vaccines elicit neutralizing immunoglobin G (IgG) antibodies that prevent severe COVID-19 but induce only weak antibody responses in mucosal tissues. There is increasing recognition that secretory immunoglobin A (SIgA) antibodies in the upper respiratory tract and oral cavity are critical in interrupting virus shedding, transmission, and progression of disease. To fully understand the immune-related factors that influence SARS-CoV-2 dynamics at the population level, it will be necessary to monitor virus-specific IgG and SIgA in systemic and mucosal compartments. Content Oral fluids and saliva, with appropriate standardized collection methods, constitute a readily accessible biospecimen type from which both systemic and mucosal antibodies can be measured. Serum-derived IgG and immunoglobin A (IgA) are found in gingival crevicular fluids and saliva as the result of transudation, while SIgA, which is produced in response to mucosal infection and vaccination, is actively transported across salivary gland epithelia and present in saliva and passive drool. In this mini-review, we summarize the need for the implementation of standards, highly qualified reagents, and best practices to ensure that clinical science is both rigorous and comparable across laboratories and institutions. We discuss the need for a better understanding of sample stability, collection methods, and other factors that affect measurement outcomes and interlaboratory variability. Summary The establishment of best practices and clinical laboratory standards for the assessment of SARS-CoV-2 serum and mucosal antibodies in oral fluids is integral to understanding immune-related factors that influence COVID-19 transmission and persistence within populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
- Division of Infectious Diseases, NewYork State Department of Health, Wadsworth Center, Albany, NY, United States.
ORCID-Profile: Kate L DeRosa, Nicholas J Mantis
Förderung
- NCI NIH HHS
- NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Heaney, C. D., Hempel, H., DeRosa, K. L., Pinto, L. A., & Mantis, N. J. (2024). Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination. Clinical Chemistry, 70(4), 589-596. https://doi.org/10.1093/clinchem/hvad169
Vancouver
Heaney CD, Hempel H, DeRosa KL, Pinto LA, Mantis NJ. Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination. Clinical Chemistry. 2024;70(4):589-596. doi:10.1093/clinchem/hvad169
BibTeX
@article{Heaney2024,
author = {Heaney, Christopher D and Hempel, Heidi and DeRosa, Kate L and Pinto, Ligia A and Mantis, Nicholas J},
title = {Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination},
journal = {Clinical Chemistry},
year = {2024},
volume = {70},
number = {4},
pages = {589--596},
doi = {10.1093/clinchem/hvad169}
}
EUVIMED